RSS Feeds | Merck Serono To Reconsider Development Of Matuzumab In Metastatic Colorectal Cancer Patients
August 31, 2007 08:00:00 Merck Serono, a division of Merck KGaA, announced that a phase II trial investigating the humanized monoclonal antibody matuzumab in combination with irinotecan in patients with metastatic colorectal cancer (mCRC) who had already failed on multiple prior treatments, including irinotecan, has not met its predefined endpoint of activity. Merck Serono is therefore reconsidering further development of matuzumab in mCRC at this stage. [click link for full article] - [Read more] |
| New 200 Mg Vial For Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience And Efficiency Of
August 28, 2007 07:00:00Sanofi-aventis U.S. launched a new 200 mg single-use vial of its chemotherapy treatment Eloxatin(R) (oxaliplatin injection) for patients who have adjuvant stage III colon cancer and advanced colorectal cancer, which is expected to offer more convenience, efficiency and safety in the preparation of the injectable cancer drug. Previously, Eloxatin(R) had been available in 50 mg and 100 mg single- use vials. [click link for full article] - [Read more] |
| Study Shines More Light On Benefit Of Vitamin D In Fighting Cancer
August 22, 2007 07:00:00A new study looking at the relationship between vitamin D serum levels and the risk of colon and breast cancer across the globe has estimated the number of cases of cancer that could be prevented each year if vitamin D3 levels met the target proposed by researchers.Cedric F. Garland, Dr.P.H. [click link for full article] - [Read more] |
| Siemens Syngo Colonography PEV For CT Colonography Examinations - A New Level Of Effectiveness
August 21, 2007 09:00:00Siemens Medical Solutions is solidifying its presence at the forefront of the market for computer-assisted reading tools in CT colonography by announcing the release of a new version of syngo Colonography PEV (Polyp Enhanced Viewing), an automated second reader tool for the visualization of lesions in the colon. The solution helps radiologists to detect polyp-shaped objects between 6 mm and 25 mm in size and can now be used both in clean-prepped and solid-liquid tagged protocols. [click link for full article] - [Read more] |
| Compounds That Color Fruits And Veggies May Protect Against Colon Cancer
August 20, 2007 07:00:00Understanding the molecular structures of compounds that give certain fruits and vegetables their rich colors may help researchers find even more powerful cancer fighters, a new study suggests.Evidence from laboratory experiments on rats and on human colon cancer cells also suggests that anthocyanins, the compounds that give color to most red, purple and blue fruits and vegetables appreciably slow the growth of colon cancer cells. [click link for full article] - [Read more] |
| Increased Risk Of Colon Cancer Recurrence Linked With Western Diet
August 17, 2007 22:00:00Colon cancer patients who eat a diet high in red meat, fatty products, refined grains, and desserts - a so-called Western diet -- may be increasing their chance of disease relapse and early death, report researchers at Dana-Farber Cancer Institute.The study, published in the Journal of the American Medical Association, involved 1,009 patients with stage III colon cancer that has been treated with both surgery and chemotherapy. [click link for full article] - [Read more] |
| DiagnoCure Acquires New High-value Diagnostic Tests For Breast And Colon Cancer
August 17, 2007 07:00:00DiagnoCure (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering lab services, today announced it has acquired Catalyst Oncology of Worcester, MA, and its lead proprietary prognostic tests for breast, colon and potentially other cancers. DiagnoCure intends to complete the development of the tests and conduct additional validating clinical studies. [click link for full article] - [Read more] |
| High Meat And Fat Diet Linked To Higher Recurrence And Death For Colon Cancer Survivors
August 15, 2007 16:00:00A new US study has found that colon cancer survivors whose diet consisted mostly of meat, refined grains, fat and desserts had a greater risk of cancer recurrence and death compared to those whose diet least resembled this pattern.The study is published in the Journal of the American Medical Association (JAMA) and is the work of Dr Jeffrey A. Meyerhardt, of the Dana-Farber Cancer Institute, Boston, and colleagues from various other research centres in the US. [click link for full article] - [Read more] |
| Increased Risk For Colorectal Polyps From Diets High In Choline
August 11, 2007 01:00:00Contrary to expectations, diets high in the nutrient choline were associated with an increased risk of some colorectal polyps, which can -- but do not always -- lead to colorectal cancer, according to a study published online in the Journal of the National Cancer Institute.Major food sources of choline include red meat, eggs, poultry, and dairy products. Choline is involved in a biochemical process known as one-carbon metabolism. [click link for full article] - [Read more] |
| Silencing Gene For TOPK Has Potential To Treat Human Colorectal Cancer
August 4, 2007 01:00:00Working with human colorectal cancer cells, a University of Minnesota team, led by cancer biologists Zigang Dong and Ann Bode, has found the potential culprit among a network of enzymes that relay signals inside cells to regulate such functions as cell growth, cancer development and programmed cell death. The work suggests that drugs designed to disable the enzyme, known as TOPK, could have anti-cancer benefits. The study appears in the journal Gastroenterology. [click link for full article] - [Read more] |
| Phase II Study Of Therapeutic Vaccine Shows Efficacy In Patients With Metastatic Colorectal Cancer
August 3, 2007 08:00:00A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd. The study found that six of the 17 metastatic colorectal cancer patients in the study showed tumor shrinkage, classified as complete or partial responses following independent expert review. [click link for full article] - [Read more] |
| YM BioSciences Initiates Patient Enrolment In Phase II Colorectal Cancer Trial With EGFR Antibody
August 1, 2007 07:00:00YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has enrolled the first five patients within the 50-patient initial cohort of its Phase II trial with nimotuzumab in combination with irinotecan for the treatment of patients with colorectal cancer who have previously failed irinotecan-containing regimens. [click link for full article] - [Read more] |
| Major European Study Links Alcohol And Bowel Cancer
July 31, 2007 18:00:00A major European study has found that drinking even one glass of wine or beer every day raises your risk of bowel cancer by around 10 per cent. And the risk goes up the more alcohol you drink. For example, drinking more than 30 grams of alcohol a day, about one litre or nearly two pints of strong lager, increases the risk by 25 per cent. [click link for full article] - [Read more] |
| Support For Colorectal Cancer Research At Vanderbilt-Ingram Cancer Center
July 31, 2007 09:00:00The Vanderbilt-Ingram Cancer Center has landed another round of support for its Specialized Program of Research Excellence (SPORE) in gastrointestinal cancer, one of only five such programs in the country. The National Cancer Institute will provide $11.8 million over the next five years to forward Vanderbilt-Ingrams innovative colorectal cancer research."We received the top score in the country in the latest pool of GI SPORE applications," said Robert J. Coffey Jr., M.D. [click link for full article] - [Read more] |
| Aspirin Reduces Colorectal Cancer Risk In Study Of Patients With Osteoarthritis
July 25, 2007 23:00:00A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer. Earlier investigations of the drugs impact on tumor development could not rule out the possibility that an observed protective effect was caused by other preventive health care measures. [click link for full article] - [Read more] |
| Search For Genes Associated With Colon Cancer Makes Major Advance
July 11, 2007 10:00:00A 10-year study involving thousands of Israeli Jews and Arabs, led by researchers from American and Israeli institutions, has yielded important new information in the search for the genes that make a person more likely to develop colon cancer. [click link for full article] - [Read more] |
| Gene For Colon Cancer Found
July 9, 2007 07:00:00Several studies published this month by research teams studying populations all over the world report finding a significant link between a gene on human chromosome 8 and the risk of developing colon cancer.One of these studies is part of a ten-year project between Michigan in the US and Israel called the Molecular Epidemiology of Colorectal Cancer involving thousands of Israeli Jews and Arabs. [click link for full article] - [Read more] |
|
|
